Results 331 to 340 of about 871,767 (407)

Precision Enhanced Bioactivity Prediction of Tyrosine Kinase Inhibitors by Integrating Deep Learning and Molecular Fingerprints Towards Cost-Effective and Targeted Cancer Therapy. [PDF]

Pharmaceuticals (Basel)
Yagin FH, Gormez Y, Colak C, Algarni A, Al-Hashem F, Ardigò LP.   +5 more
europepmc   +1 more source

Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials. [PDF]

Clin Transl Sci
Kyriacou NM, Gross AS, McLachlan AJ.
europepmc   +1 more source

Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors? [PDF]

Cancers (Basel)
Elshazly AM, Xu J, Melhem N, Abdulnaby A, Elzahed AA, Saleh T, Gewirtz DA.   +6 more
europepmc   +1 more source